Schizophrenia

  • Most Topular Stories

  • Intranasal desmopressin as an adjunct to risperidone for negative...

    Schizophrenia News
    1 Oct 2014 | 9:01 pm
    Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial. To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.
  • Schizophrenia, bipolar disorder associated with dendritic spine loss in brain

    Schizophrenia News From Medical News Today
    1 Oct 2014 | 1:00 pm
    Schizophrenia and bipolar disorder both appear to be associated with dendritic spine loss in the brain, suggesting the two distinct disorders may share common pathophysiological features.
  • Negative symptoms of schizophrenia: clinical characteristics,...

    Schizophrenia News
    1 Oct 2014 | 5:15 pm
    Schizophrenia is a complex and multifactorial disorder generally diagnosed in young adults at the time of the first psychotic episode of delusions and hallucinations. These positive symptoms can be controlled in most patients by currently-available antipsychotics.
  • Hawarden man with schizophrenia died from clozapine poisoning

    Schizophrenia News
    29 Sep 2014 | 4:17 am
    A CORONER is to seek assurances vital information about a drug prescribed for psychiatric patients is passed on to their relatives and its side-effects fully monitored. John Gittins, the coroner for North Wales East and Central, is to take the step after the death of a Hawarden man who was under the care of Flintshire's mental health team.
  • What It's Like to Have Schizophrenia

    About.com Schizophrenia: What's Hot Now
    schizophrenia.guide@about.com
    1 Oct 2014 | 4:19 am
    In schizophrenia, the most basic processes of perceiving and thinking are affected by the illness. Whether you want your loved ones to understand you better, are concerned for someone who's ill, or are simply curious, this article describes the internal experience of delusions, hallucinations, and more. Page 2.
  • add this feed to my.Alltop

    Schizophrenia News

  • Intranasal desmopressin as an adjunct to risperidone for negative...

    1 Oct 2014 | 9:01 pm
    Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial. To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.
  • Negative symptoms of schizophrenia: clinical characteristics,...

    1 Oct 2014 | 5:15 pm
    Schizophrenia is a complex and multifactorial disorder generally diagnosed in young adults at the time of the first psychotic episode of delusions and hallucinations. These positive symptoms can be controlled in most patients by currently-available antipsychotics.
  • Hawarden man with schizophrenia died from clozapine poisoning

    29 Sep 2014 | 4:17 am
    A CORONER is to seek assurances vital information about a drug prescribed for psychiatric patients is passed on to their relatives and its side-effects fully monitored. John Gittins, the coroner for North Wales East and Central, is to take the step after the death of a Hawarden man who was under the care of Flintshire's mental health team.
  • Wakefield Gets SA Chapters Running

    28 Sep 2014 | 8:03 am
    My featured person this week, Margery Wakefield, of Lansing, Michigan, has had lifelong struggles with schizophrenia, a mental health disability. For now, primarily due to medication she began taking in 1995, she is winning this highly personal battle.
  • Traditional knowledge and formulations of medicinal plants used by...

    27 Sep 2014 | 4:55 am
    Traditional knowledge and formulations of medicinal plants used by the traditional medical practitioners of bangladesh to treat schizophrenia like psychosis. Schizophrenia is a subtle disorder of brain development and plasticity; it affects the most basic human processes of perception, emotion, and judgment.
 
  • add this feed to my.Alltop

    MedWorm: Schizophrenia

  • Mental Health System Historians: Adults with Schizophrenia Describe Changes in Community Mental Health Care Over Time

    1 Oct 2014 | 3:47 pm
    Abstract This qualitative study examined changes in community mental health care as described by adults diagnosed with schizophrenia with long-term involvement in the mental health system to situate their experiences within the context of mental health reform movements in the United States. A sample of 14 adults with schizophrenia who had been consumers of mental health services from 12 to 40 years completed interviews about their hospital and outpatient experiences over time and factors that contributed most to their mental health. Overall, adults noted gradual changes in mental health care…
  • Genetic Modifiers and Subtypes in Schizophrenia

    1 Oct 2014 | 3:17 pm
    Abstract The vast differences observed in clinical features of schizophrenia are undoubtedly mediated in part by genetic influences. Schizophrenia has been conceptualized as either a collection of disorders with overlapping features or a singular diagnostic entity with modifying influences giving rise to the observed range of manifestations. Accordingly, attempts to connect genetic and phenotypic heterogeneity have predominantly investigated the genetic foundations for clinically defined subgroups or explored the effects of putative risk genes on observed variation in schizophrenia. Some…
  • What causes paranoia, hallucinations and grandiose ideas?

    30 Sep 2014 | 10:00 pm
    The widespread symptoms typically associated with schizophrenia are at least as likely to be triggered by peoples environment as their genes, a new study suggests Continue reading... (Source: Guardian Unlimited Science)
  • Excess of non-right-handedness in schizophrenia: meta-analysis of gender effects and potential biases in handedness assessment [Review articles]

    30 Sep 2014 | 4:00 pm
    Conclusions The findings clearly demonstrate that the excess of non-right-handedness in schizophrenia does not result from a gender artefact or from biased handedness questionnaires. It is a true empirical effect and may indeed reflect a genetic link between schizophrenia and brain lateralisation. (Source: The British Journal of Psychiatry)
  • Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia

    30 Sep 2014 | 4:00 pm
    Abstract Previous work from our laboratory showed deficits in tyrosine hydroxylase protein expression within the substantia nigra/ventral tegmental area (SN/VTA) in schizophrenia. However, little is known about the nature and specific location of these deficits within the SN/VTA. The present study had two aims: (1) test if tyrosine hydroxylase deficits could be explained as the result of neuronal loss; (2) assess if deficits in tyrosine hydroxylase are sub-region specific within the SN/VTA, and thus, could affect specific dopaminergic pathways. To achieve these objectives: (1) we obtained…
 
  • add this feed to my.Alltop

    About.com Schizophrenia: What's Hot Now

  • What It's Like to Have Schizophrenia

    schizophrenia.guide@about.com
    1 Oct 2014 | 4:19 am
    In schizophrenia, the most basic processes of perceiving and thinking are affected by the illness. Whether you want your loved ones to understand you better, are concerned for someone who's ill, or are simply curious, this article describes the internal experience of delusions, hallucinations, and more. Page 2.
  • The Positive and Negative Symptoms of...

    schizophrenia.guide@about.com
    1 Oct 2014 | 4:19 am
    Are you having experiences that seem unreal? Are you concerned about strange behavior in a loved one? Learn to understand and describe the symptoms of schizophrenia, so that you can communicate them to a doctor.
  • What Causes Schizophrenia?

    schizophrenia.guide@about.com
    1 Oct 2014 | 4:19 am
    Developmental theories of schizophrenia explore things that may have gone wrong during fetal and infant brain development.
  • What Do Hallucinations Feel Like in Schizophren...

    schizophrenia.guide@about.com
    1 Oct 2014 | 4:19 am
    Hallucinations are part of schizophrenia. This article focuses on what experiencing hallucinations feels like from a patient's perspective.
  • Schizophrenia Early Diagnosis

    schizophrenia.guide@about.com
    1 Oct 2014 | 4:19 am
    How early can schizophrenia be diagnosed? Are there warning signs that can guide prevention, early diagnosis and treatment?
  • add this feed to my.Alltop

    About.com Schizophrenia: Most Popular Articles

  • How Are Atypicals Different From Typical...

    1 Oct 2014 | 6:16 am
    How are atypical antipsychotics different than typical antipsychotics? Are they better medications, worse, or just about the same?
  • Schizophrenia Early Signs

    1 Oct 2014 | 6:16 am
    It is important to recognize schizophrenia as early as possible. Early diagnosis is the foundation for early intervention, which is the path to recovery,
  • The Positive and Negative Symptoms of...

    1 Oct 2014 | 6:16 am
    Are you having experiences that seem unreal? Are you concerned about strange behavior in a loved one? Learn to understand and describe the symptoms of schizophrenia, so that you can communicate them to a doctor.
  • Positive Symptoms

    1 Oct 2014 | 6:16 am
    Definition of the term, positive symptoms.
  • Atypical Antipsychotic Drugs Used to Treat...

    1 Oct 2014 | 6:16 am
    In the early 1990s a new class of drugs were developed to treat the psychotic symptoms of schizophrenia. These drugs, the atypical antipsychotics, have proven generally as effective as the antispychotics developed decades earlier, with fewer extrapyrimidal side effects. This list of the atypical antipsychotics provides links to drug safety information from the drug manufacturers' websites.
 
  • add this feed to my.Alltop

    Schizophrenia Bulletin - Advance Access

  • Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the SOP First-Episode Cohort

    Reininghaus, U., Dutta, R., Dazzan, P., Doody, G. A., Fearon, P., Lappin, J., Heslin, M., Onyejiaka, A., Donoghue, K., Lomas, B., Kirkbride, J. B., Murray, R. M., Croudace, T., Morgan, C., Jones, P. B.
    27 Sep 2014 | 1:48 am
    The excess mortality in people with psychotic disorders is a major public health concern, but little is known about the clinical and social risk factors which may predict this health inequality and help inform preventative strategies. We aimed to investigate mortality in a large epidemiologically characterized cohort of individuals with first-episode psychosis compared with the general population and to determine clinical and social risk factors for premature death. All 557 individuals with first-episode psychosis initially identified in 2 areas (Southeast London and Nottinghamshire, United…
  • Heterogeneity of Structural Brain Changes in Subtypes of Schizophrenia Revealed Using Magnetic Resonance Imaging Pattern Analysis

    Zhang, T., Koutsouleris, N., Meisenzahl, E., Davatzikos, C.
    26 Sep 2014 | 7:39 am
    Background:Schizophrenia is a multifaceted mental disorder characterized by cognitive, perceptual, and affective symptom dimensions. This heterogeneity at the phenomenological level may be subserved by complex and heterogeneous patterns of structural abnormalities. Thus, delineating such patterns may improve the insight into the variability of disease and facilitate future magnetic resonance imaging-based diagnosis.Methods:We aimed to identify structurally complex signatures that directly differentiate patients with predominantly negative (pNEG), positive (pPOS), and disorganized (pDIS)…
  • Imaging-Based Neurochemistry in Schizophrenia: A Systematic Review and Implications for Dysfunctional Long-Term Potentiation

    Salavati, B., Rajji, T. K., Price, R., Sun, Y., Graff-Guerrero, A., Daskalakis, Z. J.
    22 Sep 2014 | 8:33 pm
    Cognitive deficits are commonly observed in patients with schizophrenia. Converging lines of evidence suggest that these deficits are associated with impaired long-term potentiation (LTP). In our systematic review, this hypothesis is evaluated using neuroimaging literature focused on proton magnetic resonance spectroscopy, positron emission tomography, and single-photon emission computed tomography. The review provides evidence for abnormal dopaminergic, GABAergic, and glutamatergic neurotransmission in antipsychotic-naive/free patients with schizophrenia compared with healthy controls. The…
  • Attachment in Schizophrenia--Implications for Research, Prevention, and Treatment

    Harder, S.
    16 Sep 2014 | 10:23 pm
    Attachment is a promising area for elucidating psychosocial mechanisms important for development, prevention, and treatment of schizophrenia. This report gives a short summary of studies of attachment in psychosis. It was found that dismissing and disorganized forms of attachment were over-represented in psychosis. Evidence pointed to associations between a dismissing attachment pattern and positive psychotic symptoms, negative symptoms, and poor engagement with services. Furthermore, insecure attachment was found to predict impaired recovery from negative symptoms. Possible major risk…
  • Comparing Fractional Anisotropy in Patients With Childhood-Onset Schizophrenia, Their Healthy Siblings, and Normal Volunteers Through DTI

    Moran, M. E., Luscher, Z. I., McAdams, H., Hsu, J. T., Greenstein, D., Clasen, L., Ludovici, K., Lloyd, J., Rapoport, J., Mori, S., Gogtay, N.
    12 Sep 2014 | 12:27 am
    Background: Diffusion tensor imaging is a neuroimaging method that quantifies white matter (WM) integrity and brain connectivity based on the diffusion of water in the brain. White matter has been hypothesized to be of great importance in the development of schizophrenia as part of the dysconnectivity model. Childhood-onset schizophrenia (COS), is a rare, severe form of the illness that resembles poor outcome adult-onset schizophrenia. We hypothesized that COS would be associated with WM abnormalities relative to a sample of controls. Methods: To evaluate WM integrity in this population 39…
  • add this feed to my.Alltop

    Schizophrenia Research

  • A genetic locus in 7p12.2 associated with treatment resistant schizophrenia

    Jiang Li, Herbert Y. Meltzer
    13 Sep 2014 | 5:00 pm
    Approximately 30% of patients with schizophrenia are treatment resistant (TRS), i.e. have persistent psychotic symptoms despite adequate trials of at least two antipsychotic drugs (APDs). Most TRS patients are candidates for clozapine treatment which is underutilized because of its side effects and difficulty in identifying TRS. We conducted a genome-wide association study (GWAS) of 79 TRS and 95 non-treatment resistant (NTRS) Caucasian schizophrenia patients to identify possible biomarkers for TRS, which might also provide insight into the pathobiology of TRS.
  • Glutamate receptor 1 phosphorylation at serine 845 contributes to the therapeutic effect of olanzapine on schizophrenia-like cognitive impairments

    Chen Zhang, Yiru Fang, Lin Xu
    13 Sep 2014 | 5:00 pm
    Schizophrenia patients exhibit a wide range of impairments in cognitive functions. Clinically, atypical antipsychotic drugs (AAPs) such as olanzapine (OLZ) have a therapeutic effect on memory function among schizophrenia patients rather than typical antipsychotics, e.g., haloperidol. To date, however, little is known about the neuroplasticity mechanism underlying the effect of AAPs on the impairment of cognitive functions. Here, we treated schizophrenia rat models with a systematic injection of MK-801 (0.1mg/kg) and chose the drug OLZ as a tool to investigate the mechanisms of AAPs when used…
  • Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems

    Joao Paulo Maia-de-Oliveira, Bruno Lobão-Soares, Glen B. Baker, Serdar M. Dursun, Jaime E.C. Hallak
    13 Sep 2014 | 5:00 pm
    “Schizophrenia is arguably the worst disease affecting mankind, even AIDS not excepted”. Since this statement in 1988 (Editors, 1988), schizophrenia still remains a major challenge to medicine, with up to 60% of patients not responding adequately to treatment despite the relatively large arsenal of antipsychotics currently available. By modulating the nitric oxide (NO) pathway, a new paradigm for schizophrenia treatment apparently involving modulation of nitric oxide (NO) has been proposed (Oliveira et al., 2011).
  • No effect of schizophrenia risk genes , , and on macroscopic brain structure

    Helena Cousijn, Marc Eissing, Guillén Fernández, Simon E. Fisher, Barbara Franke, Marcel Zwiers, Paul J. Harrison, Alejandro Arias-Vásquez
    9 Sep 2014 | 5:00 pm
    Single nucleotide polymorphisms (SNPs) within the MIR137, TCF4, and ZNF804A genes show genome-wide association to schizophrenia. However, the biological basis for the associations is unknown. Here, we tested the effects of these genes on brain structure in 1300 healthy adults. Using volumetry and voxel-based morphometry, neither gene-wide effects—including the combined effect of the genes—nor single SNP effects—including specific psychosis risk SNPs—were found on total brain volume, grey matter, white matter, or hippocampal volume.
  • Diagnostic transition towards schizophrenia in adolescents with severe bipolar disorder type I: An 8-year follow-up study

    Angèle Consoli, Julie Brunelle, Nicolas Bodeau, Estelle Louët, Emmanuelle Deniau, Didier Perisse, Claudine Laurent, David Cohen
    9 Sep 2014 | 5:00 pm
    The diagnosis of bipolar disorder-I (BD-I) is currently well-established. However, more studies exploring diagnostic stability and psychosocial adaptation during follow-up in adulthood are needed.
  • add this feed to my.Alltop

    Schizophrenia Research

  • A genetic locus in 7p12.2 associated with treatment resistant schizophrenia

    Jiang Li, Herbert Y. Meltzer
    13 Sep 2014 | 5:00 pm
    Approximately 30% of patients with schizophrenia are treatment resistant (TRS), i.e. have persistent psychotic symptoms despite adequate trials of at least two antipsychotic drugs (APDs). Most TRS patients are candidates for clozapine treatment which is underutilized because of its side effects and difficulty in identifying TRS. We conducted a genome-wide association study (GWAS) of 79 TRS and 95 non-treatment resistant (NTRS) Caucasian schizophrenia patients to identify possible biomarkers for TRS, which might also provide insight into the pathobiology of TRS.
  • Glutamate receptor 1 phosphorylation at serine 845 contributes to the therapeutic effect of olanzapine on schizophrenia-like cognitive impairments

    Chen Zhang, Yiru Fang, Lin Xu
    13 Sep 2014 | 5:00 pm
    Schizophrenia patients exhibit a wide range of impairments in cognitive functions. Clinically, atypical antipsychotic drugs (AAPs) such as olanzapine (OLZ) have a therapeutic effect on memory function among schizophrenia patients rather than typical antipsychotics, e.g., haloperidol. To date, however, little is known about the neuroplasticity mechanism underlying the effect of AAPs on the impairment of cognitive functions. Here, we treated schizophrenia rat models with a systematic injection of MK-801 (0.1mg/kg) and chose the drug OLZ as a tool to investigate the mechanisms of AAPs when used…
  • Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems

    Joao Paulo Maia-de-Oliveira, Bruno Lobão-Soares, Glen B. Baker, Serdar M. Dursun, Jaime E.C. Hallak
    13 Sep 2014 | 5:00 pm
    “Schizophrenia is arguably the worst disease affecting mankind, even AIDS not excepted”. Since this statement in 1988 (Editors, 1988), schizophrenia still remains a major challenge to medicine, with up to 60% of patients not responding adequately to treatment despite the relatively large arsenal of antipsychotics currently available. By modulating the nitric oxide (NO) pathway, a new paradigm for schizophrenia treatment apparently involving modulation of nitric oxide (NO) has been proposed (Oliveira et al., 2011).
  • No effect of schizophrenia risk genes , , and on macroscopic brain structure

    Helena Cousijn, Marc Eissing, Guillén Fernández, Simon E. Fisher, Barbara Franke, Marcel Zwiers, Paul J. Harrison, Alejandro Arias-Vásquez
    9 Sep 2014 | 5:00 pm
    Single nucleotide polymorphisms (SNPs) within the MIR137, TCF4, and ZNF804A genes show genome-wide association to schizophrenia. However, the biological basis for the associations is unknown. Here, we tested the effects of these genes on brain structure in 1300 healthy adults. Using volumetry and voxel-based morphometry, neither gene-wide effects—including the combined effect of the genes—nor single SNP effects—including specific psychosis risk SNPs—were found on total brain volume, grey matter, white matter, or hippocampal volume.
  • Diagnostic transition towards schizophrenia in adolescents with severe bipolar disorder type I: An 8-year follow-up study

    Angèle Consoli, Julie Brunelle, Nicolas Bodeau, Estelle Louët, Emmanuelle Deniau, Didier Perisse, Claudine Laurent, David Cohen
    9 Sep 2014 | 5:00 pm
    The diagnosis of bipolar disorder-I (BD-I) is currently well-established. However, more studies exploring diagnostic stability and psychosocial adaptation during follow-up in adulthood are needed.
 
  • add this feed to my.Alltop

    Schizophrenia Society of Saskatchewan

  • SSS 2014 Annual General Meeting

    Schizophrenia Society of Saskatchewan
    11 Sep 2014 | 7:54 am
    You are invited to attend the Provincial Office of the Schizophrenia Society of Saskatchewan’s Annual General Meeting and Awards Luncheon Monday, September 29, 2014 11:30 a.m. – 2:00 p.m. DoubleTree by Hilton Regina Hotel and Conference Centre Swift Current Room *Please RSVP your attendance for lunch by September 26th.  Please return the attached form or by calling the SSS office at 306-584-2620 or 1-877-584-2620 or by fax at 306-584-0525 or by e-mail to sssprov@sasktel.net
  • Regina Chapter 2014 Annual General Meeting

    Schizophrenia Society of Saskatchewan
    11 Sep 2014 | 7:52 am
    Annual General Meeting The Regina Chapter of The Schizophrenia Society of Saskatchewan (SSS) Monday, September 15, 2014 Meet and greet at 6:15pm (light supper) Meeting at 7:00 pm *Please RSVP to the contact info below United Way of Regina 1440 Scarth Street Guest Speakers Anita Hopfauf- SSS Executive Director Tanya Condo-SSS Partnership Program Coordinator *The Regina Chapter is currently looking for new Board Members.  If you are interested, please email your resume to Regina Chapter President, Mike Gardiner at carmi@sasktel.net or call 306 584-2620 to leave a message.
  • Family Members and Caregiver’s Survey

    Schizophrenia Society of Saskatchewan
    17 Jul 2014 | 12:42 pm
    Are you a family member or caregiver to someone with schizophrenia,bipolar disorder, or other related mental illness? The Schizophrenia Society of Canada is doing research into the experiences of caregivers, and would like your feedback. If you are interested in taking part in this very important research, please click here to proceed to the Schizophrenia Society of Canada research page. Thank you for time and insight!
  • SSC Award Applications are now being accepted – Deadline is September 12, 2014

    Schizophrenia Society of Saskatchewan
    17 Jul 2014 | 12:37 pm
    The Schizophrenia Society of Canada is now accepting applications for their annual awards. Click here to learn more!
  • Schizophrenia Society Annual Awards – Nomination Forms

    Schizophrenia Society of Saskatchewan
    22 Jun 2014 | 2:33 pm
    The Schizophrenia Society of Saskatchewan will be handing out awards again this year September our AGM (date pending). If you are interested in nominating someone for any of the following awards, please download the appropriate form and return it to the Schizophrenia Society of Saskatchewan by Monday, July 28th, 2014. Schizophrenia Society of Saskatchewan Award Nomination Form 2014 Community Spirit Award - This award recognizes a business, corporation or organization for their outstanding community spirit in supporting the SSS in their mission to improve the quality of life of those affected…
  • add this feed to my.Alltop

    Schizophrenia News -- ScienceDaily

  • Blood test may help determine who is at risk for psychosis

    22 Sep 2014 | 8:30 am
    A blood test, when used in psychiatric patients experiencing symptoms that are considered to be indicators of a high risk for psychosis, identifies those who later went on to develop psychosis, preliminary results of a new study show. "The blood test included a selection of 15 measures of immune and hormonal system imbalances as well as evidence of oxidative stress," explained a corresponding author of the study.
  • Smoking, schizophrenia linked by alterations in brain nicotine signals

    16 Sep 2014 | 5:48 am
    Schizophrenia is associated with increased rates and intensity of tobacco smoking. A growing body of research suggests that the relationship between schizophrenia and smoking stems, in part, from an effort by patients to use nicotine to self-medicate symptoms and cognitive impairment associated with the disease. A new study sheds light on this hypothesis. The authors found that the level of nicotine receptors in the brain was lower in schizophrenia patients than in a matched healthy group.
  • Brain development in schizophrenia strays from normal path

    15 Sep 2014 | 5:37 am
    Schizophrenia is generally considered to be a disorder of brain development and it shares many risk factors, both genetic and environmental, with other neurodevelopmental disorders such as autism and intellectual disability. The normal path for brain development is determined by the combined effects of a complex network of genes and a wide range of environmental factors. However, longitudinal brain imaging studies in both healthy and patient populations are required in order to map the disturbances in brain structures as they emerge, researchers say.
  • Schizophrenia not a single disease but multiple genetically distinct disorders

    15 Sep 2014 | 5:35 am
    Schizophrenia isn’t a single disease but a group of eight genetically distinct disorders, each with its own set of symptoms, research shows. The finding could be a first step toward improved diagnosis and treatment for the debilitating psychiatric illness.
  • Neurochemical imbalance in schizophrenia discovered

    11 Sep 2014 | 9:42 am
    Using human induced pluripotent stem cells (hiPSCs), researchers have discovered that neurons from patients with schizophrenia secrete higher amounts of three neurotransmitters broadly implicated in a range of psychiatric disorders.
 
  • add this feed to my.Alltop

    Schizophrenia Society of Nova Scotia

  • The "From Recovery to Discovery" Mental Health Peer Support Group-Halifax

    1 Oct 2014 | 4:00 am
    ,Tomorrow, October 2nd, 6:30 pmMeetingsEvery Thursday Evening6:30 pm to 8:30 pmCommunity RoomAtlantic Superstore – Barrington Street 1075 Barrington StreetHalifax, Nova Scotia Plenty of free parking!The Atlantic Superstore – Barrington Street is on the 3, 7, 9, and 41 Metro Transit bus routes.The From Recovery to Discovery Mental Health Peer Support Group is open to anyone affected by any type of mental illness, and this includes family members and friends.Free! Thursday, October 2nd, 2014, 6:30 pmA Mental Health Peer Support Group MeetingTopic: To Be AnnouncedPhoto creditAbout the…
  • Janine Williams Memorial Bursary – 2014

    1 Oct 2014 | 3:30 am
    Application DeadlineFriday, October 17th, 2014, 5:00 pmIn partnership with Cole Harbour / Eastern HRM Community Mental Health, the Schizophrenia Society of Nova Scotia awards the Janine Williams Memorial Bursary, valued at $500.00, to an individual living with a mental illness who is embarking on or pursuing some form of learning through formal education or life skills development. The seventh annual Janine Williams Memorial Bursary will be awarded in November 2014.An advertising poster (PDF) to print and display in your work area and/or social settings can be downloaded by clicking here.The…
  • Getting Mental Health Crisis Support in Nova Scotia

    29 Sep 2014 | 3:30 am
    Call (902) 429-8167 or 1-888-429-8167 (toll free)The Mental Health Mobile Crisis Team (MHMCT) provides intervention and short term crisis management for children, youth and adults experiencing a mental health crisis. They offer 24/7 telephone intervention throughout Nova Scotia - (902) 429-8167 or 1-888-429-8167 (toll free) - and mobile response (1:00 pm to 1:00 am) in areas served by Halifax Regional Police including Halifax, Dartmouth and Bedford.Note that this video is two years old and it does not mention the 24/7 telephone crisis intervention service that is now available throughout Nova…
  • How to refer someone to the Nova Scotia Early Psychosis Program

    29 Sep 2014 | 3:00 am
    From the Nova Scotia Early Psychosis Program (NSEPP) website:Because NSEPP is located in Halifax, within the largest of the Nova Scotia health regions; Capital Health, the program provides direct clinical services to residents of the Capital Health district.Referrals to NSEPP can be made by anyone, including mental health care professionals, family physicians, community agencies, educators and school counselors, family members, friends and any young person who suspects they may be suffering from a first episode of psychosis.Criteria for referral of individuals who reside in the Capital Health…
  • Assistance with navigating mental health services in the Capital Health district

    29 Sep 2014 | 2:30 am
    404-3504 ext. 201From the Healthy Minds Cooperative's February 2013 newsletter:NavigationGoing through the mental health system can be like trying to find your way through a maze. Navigation is a service that the Healthy Minds Cooperative provides that helps guide people living with a mental illness, and their families, to connect with support services in the community. The Navigator can answer your questions and concerns about:Services in the communitySupport groupsPrograms and workshopsReferral ServicesAdvocacyWeb-based resourcesFor more information about navigation, please call (902)…
  • add this feed to my.Alltop

    schizophrenic.com

  • Schizophrenia and bipolar study aims to create most comprehensive resource to date

    M Tyler
    26 Sep 2014 | 10:54 am
    A national team of researchers was recently awarded a $16 million grant from the National Institute of Mental Health (NIMH) to create a genetic resource of schizophrenia and biplar disorder from DNA samples, the University of Southern California reports. The funding, which will be shared by researchers from USC, the University of Michigan and the Broad Institute Inc., will go toward better understanding the genetic basis of schizophrenia and bipolar disorder, while identifying new targets for drugs or therapies. “This study will greatly increase the data available on the human genomic…
  • Schizophrenia isn't a single disease, but eight specific genetic disorders

    M Tyler
    25 Sep 2014 | 7:54 am
    Clusters of genes working together, instead of individual genes, pose the most risk for developing schizophrenia, according to a new study at Washington University School of Medicine in St. Louis. Researchers found that there are specific groups of genes that can contribute to eight different variations of schizophrenia - each with a unique set of symptoms. While individual genes can have some associations with schizophrenia, groups of these genes interacting with one another can significantly increase the risk of illness, by 70 to 100 percent, reports Jim Dryden on Washington University's…
  • Blood test could determine psychosis risk

    M Tyler
    23 Sep 2014 | 4:48 pm
    For psychiatric patients that are considered high risk for psychosis, a simple blood test could help medical providers get a head start on treatment. Researchers from University of North Carolina at Chapel Hill found that the test could accurately identify which patients would go on to develop psychotic symptoms, such as hallucinations or delusions. "The blood test included a selection of 15 measures of immune and hormonal system imbalances as well as evidence of oxidative stress," said study author Diana O. Perkins, MD, MPH, professor of psychiatry in the UNC School of Medicine. Further…
  • The smoking-schizophrenia relationship caused by altered brain signals

    M Tyler
    18 Sep 2014 | 11:36 am
    Schizophrenia has long been associated with increased smoking rates, and new research suggests that nicotine receptors in the brain are less present in schizophrenia patients than in healthy controls. The findings suggest that smoking for schizophrenics may not produce the same "high" that it does for others, which would then cause these individuals to smoke more in order to achieve the same effects. A target for developing treatments Interestingly, the researchers found that lower nicotine receptors availability in smokers with schizophrenia was associated with poorer performance on tests of…
  • Marijuana compound could be used to treat psychosis

    M Tyler
    16 Sep 2014 | 1:15 pm
    Despite emerging research that suggests a link between marijuana use and psychosis, a new study suggests some of the plant's properties may actually prevent the condition - which is often characterized by hallucinations, delusional thinking and loss of touch with reality. Patrick McGorry, psychiatrist, health advocate and director of the Orygen Youth Health Research Centre in Australia, said that one component of marijuana, cannabidoil (CBD), appears to help relieve psychosis, anxiety and depression. Given increasing concerns about the long-term side effects of antipsychotic medications,…
  • add this feed to my.Alltop

    Schiz Life

  • Is Schizophrenia 8 Distinct Disorders?

    Schiz Life
    18 Sep 2014 | 9:01 am
    We have all likely pondered over the many various types of schizophrenia and the wide range of symptoms that can manifest and realized how different some of them are.  It seems like we might be dealing with several distinct disorders from a surface viewpoint.  There has been little support for this concept “under the hood” when considering neurological and genetic factors, until now. “Multiple Genetically Distinct Disorders” Researchers at the Washington University School of Medicine reported some intriguing results in the American Journal of Psychiatry on the 15th…
  • Amy’s Story: Living with Schizophrenia

    Schiz Life
    6 Sep 2014 | 4:45 pm
    The following is a post by our friend Amy Kay, who has begun, recently and courageously, to voice and share her experiences with schizophrenia on her blog Voice of a Schizophrenic.  We are happy to share her story.. I used to tell people “I have a bad brain.” I am not going to say I suffer from schizophrenia but rather I endure and cope with it. My name is Amy Kay and I have schizophrenia. I do not want to hurt others or myself. Neither do I hear voices and I no longer live in a delusional world. In 2008 during my initial psychiatric breakdown it started with a state of euphoria.
  • New Schizophrenia Dimmer Switch Medication Concept

    Schiz Life
    12 Aug 2014 | 12:51 pm
    As we all know, schizophrenia medication can cause a rash of ill effects in it’s users, often times to the point that the disruption from the medication is subjectively worse than the symptoms of the illness they are meant to treat.  Finding the right balance of medications to properly treat the problem without creating addition side effects can be a long and drawn out process that is frustrating to the patient and the doctor.  However, a breakthrough in this process may have just occurred… Yesterday, the Monash University in Melbourne, Australia published its findings (read the…
  • The 12 Core Functions: Your Therapist and Treatment Path

    Schiz Life
    20 Jul 2014 | 5:43 am
    The 12 Core Functions: Your Therapist and Treatment Path A sad reality is that many people dealing with the symptoms of schizophrenia simply fail to receive treatment.  There are lots of various reasons why this can happen, but one of the reasons is a resistance and fear in not understanding how treatment will transpire.  This article is meant to give the reader a general overview of what the therapist is thinking and the guidelines they follow to perform their task.  Your treatment will be personalized and tailored specifically to your experiences, symptoms, and receptiveness, but it will…
  • Schizophrenia Spectrum Disorders

    Schiz Life
    25 May 2014 | 1:52 pm
    What is schizophrenia spectrum disorder? How is it diagnosed and treated? A better understanding of this disorder might be derived from an understanding of the terms used to identify it. Schizophrenia is a mental disorder characterized by reduced emotional expression, abnormal social behavior and the inability to distinguish what is real and what isn’t. Persons with schizophrenia might talk about hearing voices, experience hallucinations, and suffer delusions. Spectrum refers to a range of linked conditions sometimes extending to include singular symptoms and disorders, as they relate…
 
Log in